Press release - 21/05/2026 Breakthrough in synthetic cell research Living systems such as cells rely on membrane pores and channels to transport molecules, exchange signals, and organize biochemical reactions. These functions emerge from dynamic interactions between molecular components. Researchers at the University of Stuttgart have used DNA nanotechnology to develop a synthetic membrane architecture that mimics such interactions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/breakthrough-synthetic-cell-research
Press release - 15/05/2026 Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
Press release - 13/05/2026 “AI doesn't really have a clue what it's doing” AI is transforming science and does not stop at neuroscience. In this interview, we speak to Gabriele Lohmann about her research at the intersection of the brain and algorithms. She talks about the use of artificial intelligence as a research tool, the decoding of brain activity, and why large language models do not understand what they are doing.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-doesnt-really-have-clue-what-its-doing
Press release - 11/05/2026 What Really Helps People Quit Smoking Whether people try to quit smoking depends heavily on public health policies in their respective countries – whether they are successful, however, depends primarily on their personal environment and behavior. This was the finding of researchers from the German Cancer Research Center (DKFZ) in an international study.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-really-helps-people-quit-smoking
Press release - 23/04/2026 Molecular research: When speed meets precision Within biological cells, molecules are constantly in motion. Investigating these motions, however, is still difficult, due to the fact that these processes occur on very small length and time scales. To overcome these challenges, researchers from HITS and MPI-P have developed a simulation method that works rapidly and can predict chemical processes in cells with high precision. Their findings have been published in Nature Communications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-when-speed-meets-precision
Press release - 07/04/2026 The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning. https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
Press release - 07/04/2026 The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning. https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
Press release - 24/03/2026 Ovarian Cancer: Adipose Tissue Influences the Efficacy of Immunotherapy In ovarian cancer, immunotherapies using checkpoint inhibitors have so far been effective in only a small number of patients. Researchers at the HI-TRON Mainz* have now discovered that lipid metabolism processes in the tumor microenvironment play a decisive role in how well such therapies work. The findings open up new avenues for using immunotherapies in a more targeted manner, increasing their effectiveness, and overcoming resistance.https://www.gesundheitsindustrie-bw.de/en/article/press-release/eierstockkrebs-fettgewebe-beeinflusst-wirksamkeit-der-immuntherapie
Press release - 25/02/2026 Magnetic Microrobot Swarms Enable Contactless Manipulation of Objects Through Fluidic Torque In a study, a team of researchers show that groups of magnetic microrobots can generate fluidic forces strong enough to rotate objects in different directions without touching them. These microrobot swarms can turn gear systems, rotate objects much larger than the robots themselves, assemble structures on their own, and even pull in or push away many small objects. The work was now published in Science Advances.https://www.gesundheitsindustrie-bw.de/en/article/press-release/magnetic-microrobot-swarms-enable-contactless-manipulation-objects-through-fluidic-torque
Press release - 10/02/2026 CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary Brain-Computer Interface system in a clinical trial. The implantation follows neurological gains observed in the study’s first participant. This represents another key milestone to evaluate CorTec’s fully implantable closed-loop BCI platform for therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cortec-announces-successful-second-human-implantation-its-brain-computer-interface-bci-system
Press release - 27/01/2026 Using AI to Retrace the Evolution of Genetic Control Elements in the Brain Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum. An international research team led by biologists from Heidelberg University as well as the Vlaams Instituut voor Biotechnologie and KU Leuven has now developed advanced AI models that can predict the activity of these elements based solely on their DNA sequence. https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-ai-retrace-evolution-genetic-control-elements-brain
Press release - 26/01/2026 AI learns from animals: New approach to improve surgical imaging Scientists at the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), and Mannheim University Medical Center (UMM) are presenting a method that enables artificial intelligence (AI) to learn how to transfer medical image data from animals to humans. This “xeno-learning” could help make surgical procedures safer and more precise in the future – without relying on human training data.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-learns-animals-new-approach-improve-surgical-imaging
Press release - 17/12/2025 Improving cancer therapy with artificial organs DFG funds research training group "Org-BOOST" with around nine million euros Recreating tumour tissue in the laboratory as realistically as possible and developing new approaches for personalised cancer medicine: A total of 20 doctoral students in the life sciences and ten Medicine students will be researching this in the new "Organoid-Based mOdelling of Solid Tumours" research training group. They want to gain a better understanding of cancer and better predict the course of the disease and the effect of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/improving-cancer-therapy-artificial-organs-dfg-funds-research-training-group-org-boost-around-nine-million-euros
Press release - 04/12/2025 AI-supported molecular cancer diagnosis for brain tumors Researchers at the Hopp Children's Cancer Center Heidelberg, the German Cancer Research Center, the Heidelberg Medical Faculty of Heidelberg University, and Heidelberg University Hospital have taken a decisive step toward more precise diagnosis of brain tumors. The latest version of the AI-based Heidelberg CNS Tumor Methylation Classifier can identify more than 180 tumor types —twice as many as the previous version. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-supported-molecular-cancer-diagnosis-brain-tumors
Press release - 28/11/2025 New RNA Class Discovered that Helps Keep Cells Organized Inside cells, RNAs and proteins form biomolecular condensates. These droplets are essential for organizing cellular life, yet why some RNAs cluster more readily than others has remained unclear. Disruptions in condensate formation are linked to developmental defects, cancer, and neurodegenerative diseases. Researchers at KIT have now identified a new class of RNA called smOOPs and gained a better understanding of how biomolecular condensates formhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-rna-class-discovered-helps-keep-cells-organized
Press release - 25/11/2025 CELLnROLL receives funding from EXIST Research Transfer CELLnROLL is a spin-off from the Max Planck Institute for Intelligent Systems. The newly founded company develops a high-precision microrobotic-based cell sorting system to help clinicians make fast, affordable, and informed decisions for cancer diagnostics. Now, the project has received €865,000 in funding through the EXIST Transfer of Research program, a funding program initiated by the German Federal Ministry for Economic Affairs and Energy. https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellnroll-receives-funding-exist-research-transfer
Press release - 13/11/2025 Software optimizes simulations of the brain A new software enables brain simulations which both imitate the processes in the brain in detail and can solve challenging cognitive tasks. The program was developed by a research team at the Cluster of Excellence ‘Machine Learning: New Perspectives for Science’ at the University of Tübingen. The software thus forms the basis for a new generation of brain simulations which allow deeper insights into the functioning and performance of the brain.https://www.gesundheitsindustrie-bw.de/en/article/press-release/software-optimizes-simulations-brain
Press release - 23/10/2025 Predicting Avian Flu Outbreaks in Europe Using Machine Learning Heidelberg researchers identify local outbreak indicators and develop new regional modeling approach. The highly pathogenic avian influenza virus infection – commonly known as bird flu – primarily affects birds. Mammals, however, are also increasingly infected. This increases the probability that the virus will cross over to humans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-avian-flu-outbreaks-europe-using-machine-learning
Enhancing human perception of the imperceptible - 28/08/2025 AI-driven imaging expands possibilities in surgery Doctors frequently experience a restricted view of the surgical field, particularly during endoscopic procedures. A novel technique developed by Prof. Dr. Lena Maier-Hein's team at the DKFZ in Heidelberg integrates spectral imaging with AI-driven data analysis. This innovation facilitates accurate tissue differentiation and delivers real-time insights into organ function.https://www.gesundheitsindustrie-bw.de/en/article/news/ai-driven-imaging-expands-possibilities-surgery
Press release - 12/08/2025 Biomarkers for Brain Insulin Resistance Discovered in the Blood If the brain no longer responds properly to insulin (insulin resistance), this can lead to overweight, diabetes, and Alzheimer's disease. Researchers at the DZD in Potsdam and Tübingen have discovered small chemical modifications to genetic material (epigenetic changes*) in the blood that indicate how well the brain responds to insulin. These markers could help to detect insulin resistance in the brain – by means of a simple blood test.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biomarkers-brain-insulin-resistance-discovered-blood
Press release - 29/07/2025 New method to design custom protein binder Designing protein binders from scratch has long been a daunting challenge within the field of computational biology. Researchers have now developed an innovative, training-free pipeline that uses the fundamental principle of shape complementarity to design site-specific protein binders, which are then optimised to fit precisely onto chosen target sites. The researchers tested this on proteins linked to cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-method-design-custom-protein-binder
Press release - 23/07/2025 Floppy and flexible: How Machine Learning helps to build new proteins A team of researchers from HITS and MPIP have developed a model that learns how to generate proteins whose structures are highly flexible, even with patterns that are uncommon in natural proteins. Their work, presented at the International Conference on Machine Learning (ICML), marks a step towards the goal of designing new proteins for applications in biotechnology, therapeutics and environmental research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/floppy-and-flexible-how-machine-learning-helps-build-new-proteins
AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025 EmbryoNet AI automatically identifies developmental disorders In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.https://www.gesundheitsindustrie-bw.de/en/article/news/embryonet-ai-automatically-identifies-developmental-disorders
Press release - 22/05/2025 Six Clusters of Excellence for the University of Tübingen Tübingen achieves remarkable success and has good chance of maintaining its University of Excellence title – Top research in three areas to be sustained from other sources of support.https://www.gesundheitsindustrie-bw.de/en/article/press-release/six-clusters-excellence-university-tubingen
Press release - 15/05/2025 Ground-breaking ceremony for new Cyber Valley building in Stuttgart A building with 7400 m² of research space for robotics and artificial intelligence is being built on the Max Planck Campus in Büsnau. Researchers from the Max Planck Institute for Intelligent Systems (MPI-IS) and the University of Stuttgart will be working there with partners from science and industry as well as start-ups from 2027.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ground-breaking-ceremony-new-cyber-valley-building-stuttgart